IFNA1 and systemic sclerosis: Excessive and persistent IFN signaling has been linked to multiple autoimmune diseases, including myositis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjogren’s syndrome, and systemic sclerosis (34).